| Typicality: | 0.289 |
| Saliency: | 0.298 |
| to insulin | 12 | transitive-object |
| to anti-angiogenic inhibitors | 2 | transitive-object |
| by altering chemical signals | 2 | manner |
| obesity → cause → resistance | 12 |
| obesity → promote → resistance | 3 |
| negative | neutral | positive |
| 0.733 | 0.256 | 0.011 |
| Raw frequency | 15 |
| Normalized frequency | 0.298 |
| Modifier score | 0.500 |
| Perplexity | 179.434 |